Return to CG147 Overview

Peripheral arterial disease: diagnosis and management [CG147]

Measuring the use of this guidance

Recommendation: 1.2.1

Offer all people with peripheral arterial disease information, advice, support and treatment regarding the secondary prevention of cardiovascular disease, in line with published NICE guidance (see Related NICE guidance; section 6) on: • smoking cessation • diet, weight management and exercise • lipid modification and statin therapy • the prevention, diagnosis and management of diabetes • the prevention, diagnosis and management of high blood pressure • antiplatelet therapy

What was measured: Proportion of patients with peripheral arterial disease with a record in the preceding 12 months that aspirin or an alternative anti-platelet is being taken.
Data collection end: March 2015
86.4%
Area covered: England
Source: Health and Social Care Information Centre. Quality Outcomes Framework.

What was measured: PAD004: The percentage of patients with peripheral arterial disease with a record in the preceding 12 months that aspirin or an alternative anti-platelet is being taken.
Data collection end: March 2016
86.7%
Data collection end: March 2017
87.1%
Area covered: National
Source: Health and Social Care Information Centre. Quality and Outcomes Framework.



 Return to CG147 Overview